These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31377894)

  • 1. Attitudes Toward Long-Term Use of Antiretroviral Therapy Among HIV-Infected Pregnant Women in Moshi, Tanzania: A Longitudinal Study.
    Minja L; Cichowitz C; Knettel BA; Mahande MJ; Kisigo G; Knippler ET; Ngocho JS; Mmbaga BT; Watt MH
    AIDS Behav; 2019 Sep; 23(9):2610-2617. PubMed ID: 31377894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa.
    Ramlagan S; Rodriguez VJ; Peltzer K; Ruiter RAC; Jones DL; Sifunda S
    AIDS Behav; 2019 Sep; 23(9):2576-2587. PubMed ID: 31228026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
    Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
    Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
    AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.
    Watt MH; Cichowitz C; Kisigo G; Minja L; Knettel BA; Knippler ET; Ngocho J; Manavalan P; Mmbaga BT
    AIDS Care; 2019 Jun; 31(6):687-698. PubMed ID: 30466304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stigma, Facility Constraints, and Personal Disbelief: Why Women Disengage from HIV Care During and After Pregnancy in Morogoro Region, Tanzania.
    McMahon SA; Kennedy CE; Winch PJ; Kombe M; Killewo J; Kilewo C
    AIDS Behav; 2017 Jan; 21(1):317-329. PubMed ID: 27535755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
    Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
    Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
    Ngarina M; Tarimo EA; Naburi H; Kilewo C; Mwanyika-Sando M; Chalamilla G; Biberfeld G; Ekstrom AM
    PLoS One; 2014; 9(1):e85310. PubMed ID: 24465532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
    McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring patterns and predictors of suicidal ideation among pregnant and postpartum women living with HIV in Kilimanjaro, Tanzania.
    Knettel BA; Mwamba RN; Minja L; Goldston DB; Boshe J; Watt MH;
    AIDS; 2020 Sep; 34(11):1657-1664. PubMed ID: 32701584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia.
    Tarekegn M; Baru A; Seme A
    Sex Reprod Healthc; 2019 Dec; 22():100459. PubMed ID: 31442747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "At home, no one knows": A qualitative study of retention challenges among women living with HIV in Tanzania.
    Kisigo GA; Ngocho JS; Knettel BA; Oshosen M; Mmbaga BT; Watt MH
    PLoS One; 2020; 15(8):e0238232. PubMed ID: 32853233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
    Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
    AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.